A detailed history of West Family Investments, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, West Family Investments, Inc. holds 2,664 shares of VRTX stock, worth $1.2 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
2,664
Previous 2,538 4.96%
Holding current value
$1.2 Million
Previous $1.19 Million 4.12%
% of portfolio
0.43%
Previous 0.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$460.0 - $505.78 $57,960 - $63,728
126 Added 4.96%
2,664 $1.24 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $17,938 - $19,627
44 Added 1.76%
2,538 $1.06 Million
Q2 2023

Aug 15, 2023

BUY
$314.42 - $351.91 $9,432 - $10,557
30 Added 1.22%
2,494 $877,000
Q1 2023

May 03, 2023

BUY
$283.23 - $323.1 $7,363 - $8,400
26 Added 1.07%
2,464 $776,000
Q4 2022

Feb 08, 2023

SELL
$285.76 - $321.48 $80,298 - $90,335
-281 Reduced 10.33%
2,438 $704,000
Q3 2022

Nov 04, 2022

BUY
$273.83 - $305.53 $35,597 - $39,718
130 Added 5.02%
2,719 $787,000
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $7,048 - $8,776
-30 Reduced 1.15%
2,589 $730,000
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $68,861 - $81,161
311 Added 13.47%
2,619 $683,000
Q4 2021

Feb 07, 2022

BUY
$177.01 - $223.45 $175,239 - $221,215
990 Added 75.11%
2,308 $507,000
Q3 2021

Oct 25, 2021

SELL
$181.39 - $202.99 $301,832 - $337,775
-1,664 Reduced 55.8%
1,318 $239,000
Q2 2021

Aug 12, 2021

BUY
$187.49 - $221.1 $559,095 - $659,320
2,982 New
2,982 $601,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track West Family Investments, Inc. Portfolio

Follow West Family Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.